

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44016064 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.92721973 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.91524045 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.91524045 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.91524045 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.91524045 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.91524045 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.91524045 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 4.55437372 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.45332356 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.41458631 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.33935569 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31137687 |
| 14 | response to interleukin-15 (GO:0070672) | 4.24163207 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 4.15388637 |
| 16 | response to peptidoglycan (GO:0032494) | 4.11392815 |
| 17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.10433089 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04950663 |
| 19 | regulation of activation of Janus kinase activity (GO:0010533) | 4.03585227 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.95010213 |
| 21 | granulocyte activation (GO:0036230) | 3.94584631 |
| 22 | neutrophil activation (GO:0042119) | 3.93005375 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.92791409 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88610053 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.85323213 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84253377 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 3.84135573 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 3.81160566 |
| 29 | cellular extravasation (GO:0045123) | 3.80757911 |
| 30 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.80059638 |
| 31 | positive regulation of interleukin-12 production (GO:0032735) | 3.79547242 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78851432 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78851432 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.74735331 |
| 35 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.73327386 |
| 36 | interferon-gamma production (GO:0032609) | 3.72947158 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.70858445 |
| 38 | myeloid dendritic cell activation (GO:0001773) | 3.70808468 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.66188711 |
| 40 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.61968904 |
| 41 | natural killer cell mediated immunity (GO:0002228) | 3.61968904 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.61917709 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.61191919 |
| 44 | detection of other organism (GO:0098543) | 3.61177695 |
| 45 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.58714535 |
| 46 | neutrophil mediated immunity (GO:0002446) | 3.55188802 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.54157222 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53718561 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.52934972 |
| 50 | NIK/NF-kappaB signaling (GO:0038061) | 3.51684700 |
| 51 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.50406452 |
| 52 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.48176704 |
| 53 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.47511823 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.47164759 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.47164759 |
| 56 | response to type I interferon (GO:0034340) | 3.45287495 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44620383 |
| 58 | leukocyte aggregation (GO:0070486) | 3.43365695 |
| 59 | negative thymic T cell selection (GO:0045060) | 3.43155855 |
| 60 | response to host immune response (GO:0052572) | 3.42792398 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42792398 |
| 62 | activated T cell proliferation (GO:0050798) | 3.42062715 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39186283 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.38235534 |
| 65 | positive regulation of interleukin-2 production (GO:0032743) | 3.34332071 |
| 66 | negative regulation of interleukin-17 production (GO:0032700) | 3.34265670 |
| 67 | tolerance induction (GO:0002507) | 3.33763986 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31720262 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.31668053 |
| 70 | negative T cell selection (GO:0043383) | 3.30145998 |
| 71 | regulation of tolerance induction (GO:0002643) | 3.30107081 |
| 72 | defense response to protozoan (GO:0042832) | 3.27033886 |
| 73 | respiratory burst (GO:0045730) | 3.27030354 |
| 74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.25413443 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 3.24840616 |
| 76 | myeloid leukocyte mediated immunity (GO:0002444) | 3.24506166 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24228640 |
| 78 | positive T cell selection (GO:0043368) | 3.23299385 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23245748 |
| 80 | positive regulation of interleukin-17 production (GO:0032740) | 3.22990688 |
| 81 | regulation of interleukin-12 production (GO:0032655) | 3.22729501 |
| 82 | positive regulation of interferon-beta production (GO:0032728) | 3.22172248 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.21455435 |
| 84 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.21455435 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 3.20889882 |
| 86 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.19706704 |
| 87 | T cell migration (GO:0072678) | 3.19554548 |
| 88 | regulation of T-helper cell differentiation (GO:0045622) | 3.18725221 |
| 89 | dendritic cell chemotaxis (GO:0002407) | 3.16212765 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 3.13731929 |
| 91 | regulation of interleukin-17 production (GO:0032660) | 3.13311261 |
| 92 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.12563174 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11438445 |
| 94 | response to host (GO:0075136) | 3.11438445 |
| 95 | response to host defenses (GO:0052200) | 3.11438445 |
| 96 | detection of bacterium (GO:0016045) | 3.11343998 |
| 97 | dendritic cell migration (GO:0036336) | 3.11252363 |
| 98 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.10777705 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 3.08538776 |
| 100 | microglial cell activation (GO:0001774) | 3.07659499 |
| 101 | regulation of RIG-I signaling pathway (GO:0039535) | 3.07464689 |
| 102 | dendritic cell differentiation (GO:0097028) | 3.07323237 |
| 103 | regulation of T-helper 1 type immune response (GO:0002825) | 3.05935930 |
| 104 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05664171 |
| 105 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.05253281 |
| 106 | cellular response to zinc ion (GO:0071294) | 3.02539742 |
| 107 | regulation of hypersensitivity (GO:0002883) | 3.02215252 |
| 108 | monocyte chemotaxis (GO:0002548) | 3.02202100 |
| 109 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.00583492 |
| 110 | negative regulation of cell killing (GO:0031342) | 3.00396202 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00396202 |
| 112 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.00008790 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99966707 |
| 114 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.99687996 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99564110 |
| 116 | regulation of T cell tolerance induction (GO:0002664) | 2.99192991 |
| 117 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.98992804 |
| 118 | B cell mediated immunity (GO:0019724) | 2.98341881 |
| 119 | detection of biotic stimulus (GO:0009595) | 2.97732939 |
| 120 | regulation of immunoglobulin secretion (GO:0051023) | 2.97435129 |
| 121 | cellular response to interferon-beta (GO:0035458) | 2.95822184 |
| 122 | regulation of B cell differentiation (GO:0045577) | 2.95463060 |
| 123 | positive regulation of isotype switching (GO:0045830) | 2.95370865 |
| 124 | positive regulation of tolerance induction (GO:0002645) | 2.94846858 |
| 125 | germinal center formation (GO:0002467) | 2.93829552 |
| 126 | positive regulation of interleukin-10 production (GO:0032733) | 2.93436558 |
| 127 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93171251 |
| 128 | regulation of chronic inflammatory response (GO:0002676) | 2.92891116 |
| 129 | response to protozoan (GO:0001562) | 2.92356855 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.90793735 |
| 131 | positive thymic T cell selection (GO:0045059) | 2.90387673 |
| 132 | T cell selection (GO:0045058) | 2.90099168 |
| 133 | leukocyte mediated cytotoxicity (GO:0001909) | 2.89809962 |
| 134 | regulation of memory T cell differentiation (GO:0043380) | 2.89612623 |
| 135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89172164 |
| 136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.87749696 |
| 137 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87589012 |
| 138 | macrophage activation (GO:0042116) | 2.87159815 |
| 139 | positive regulation of mast cell activation (GO:0033005) | 2.85335595 |
| 140 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.84395083 |
| 141 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84352165 |
| 142 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84172956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.72389931 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.62735146 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.89337589 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.84250572 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.55271876 |
| 6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28452541 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.22323783 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.21948032 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85475781 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.59443941 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51618196 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49386539 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.06560236 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06471904 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.03897880 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.99126723 |
| 17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96461128 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90530920 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41217311 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.40892305 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34741662 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.29244968 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14698555 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13108965 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03788912 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99458285 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.89274351 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88303329 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85671686 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.79373634 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79157958 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78020896 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76661821 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71848786 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70010438 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68578610 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67009059 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65341959 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64449084 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63671527 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61442364 |
| 42 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61286371 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55760636 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55414387 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52142829 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51404466 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48842380 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47619124 |
| 49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47121936 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45981883 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42410751 |
| 52 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41640517 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34095949 |
| 54 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.32299390 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31543191 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27952399 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26843992 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26568991 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21143001 |
| 60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.19154593 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18262832 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16177271 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15729716 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14439781 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14116167 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11914992 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11088301 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09509543 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08226595 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07688242 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06297761 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04310865 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03803724 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03728576 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01640246 |
| 76 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00675789 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00547093 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00402132 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00152641 |
| 80 | * MAF_26560356_Chip-Seq_TH2_Human | 0.98664580 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98662410 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98266866 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96906363 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 0.95148531 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93323871 |
| 86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93247331 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92527921 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91983303 |
| 89 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91547649 |
| 90 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91254030 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90897886 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89555761 |
| 93 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.88194510 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87474343 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87225000 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87135227 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86989016 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86367258 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85631436 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85359830 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85320740 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84968293 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84380811 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82778826 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82713666 |
| 106 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.80996507 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.80306560 |
| 108 | P300_19829295_ChIP-Seq_ESCs_Human | 0.78410030 |
| 109 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78387624 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78145615 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77629040 |
| 112 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.77595935 |
| 113 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.77548361 |
| 114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77108735 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75685177 |
| 116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75685177 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73828288 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73643475 |
| 119 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73387180 |
| 120 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72010811 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71846043 |
| 122 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68707500 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68697698 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.67946249 |
| 125 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.67928002 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67896683 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67405829 |
| 128 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67304402 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66846508 |
| 130 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.65519168 |
| 131 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64408127 |
| 132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62009940 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61033240 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.60844512 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59702614 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.58808621 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58239699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.16942151 |
| 2 | MP0009785_altered_susceptibility_to | 3.75806067 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.69391995 |
| 4 | MP0003436_decreased_susceptibility_to | 3.59569819 |
| 5 | MP0005671_abnormal_response_to | 3.53715750 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.36419001 |
| 7 | MP0000685_abnormal_immune_system | 3.32585975 |
| 8 | MP0001790_abnormal_immune_system | 3.20893122 |
| 9 | MP0005387_immune_system_phenotype | 3.20893122 |
| 10 | MP0006082_CNS_inflammation | 3.11685988 |
| 11 | MP0003303_peritoneal_inflammation | 3.04684921 |
| 12 | MP0002419_abnormal_innate_immunity | 2.98465466 |
| 13 | MP0005025_abnormal_response_to | 2.95460933 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.84129796 |
| 15 | MP0001800_abnormal_humoral_immune | 2.81417823 |
| 16 | MP0002723_abnormal_immune_serum | 2.73392856 |
| 17 | MP0004510_myositis | 2.68176054 |
| 18 | MP0003724_increased_susceptibility_to | 2.65994058 |
| 19 | MP0001819_abnormal_immune_cell | 2.54811147 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.50677216 |
| 21 | MP0002006_tumorigenesis | 2.26167510 |
| 22 | MP0002405_respiratory_system_inflammati | 2.12928173 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.01799792 |
| 24 | MP0002398_abnormal_bone_marrow | 1.95484495 |
| 25 | MP0001853_heart_inflammation | 1.94040988 |
| 26 | MP0005310_abnormal_salivary_gland | 1.93838405 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.93769403 |
| 28 | MP0000716_abnormal_immune_system | 1.92702015 |
| 29 | MP0004947_skin_inflammation | 1.86914022 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.82926540 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.81497719 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.81367101 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.80929577 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.80456489 |
| 35 | MP0003448_altered_tumor_morphology | 1.79276827 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.73951195 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.71727989 |
| 38 | MP0009764_decreased_sensitivity_to | 1.63758411 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.57388176 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.55064352 |
| 41 | MP0008260_abnormal_autophagy | 1.54988510 |
| 42 | MP0002429_abnormal_blood_cell | 1.54547796 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.51524927 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.50513922 |
| 45 | MP0002722_abnormal_immune_system | 1.47853164 |
| 46 | MP0000858_altered_metastatic_potential | 1.47199357 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.43918802 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.43918802 |
| 49 | MP0008469_abnormal_protein_level | 1.41830265 |
| 50 | MP0006054_spinal_hemorrhage | 1.41204183 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.32035937 |
| 52 | MP0004883_abnormal_blood_vessel | 1.30034973 |
| 53 | MP0009278_abnormal_bone_marrow | 1.29644150 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.26372407 |
| 55 | MP0003075_altered_response_to | 1.25928572 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.25231337 |
| 57 | MP0000343_altered_response_to | 1.23473775 |
| 58 | MP0001873_stomach_inflammation | 1.22807675 |
| 59 | MP0002163_abnormal_gland_morphology | 1.20568119 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.16316882 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.14365299 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.12489102 |
| 63 | MP0002933_joint_inflammation | 1.09468413 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.08104416 |
| 65 | MP0003787_abnormal_imprinting | 1.06571305 |
| 66 | MP0010307_abnormal_tumor_latency | 1.04729032 |
| 67 | MP0002254_reproductive_system_inflammat | 1.04484689 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.01504550 |
| 69 | MP0005451_abnormal_body_composition | 1.01128608 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.99198831 |
| 71 | MP0005166_decreased_susceptibility_to | 0.95855334 |
| 72 | MP0005248_abnormal_Harderian_gland | 0.92956313 |
| 73 | MP0001851_eye_inflammation | 0.92476128 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.90315100 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.88952312 |
| 76 | MP0000604_amyloidosis | 0.86990668 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.86552390 |
| 78 | MP0005390_skeleton_phenotype | 0.86197981 |
| 79 | MP0000490_abnormal_crypts_of | 0.85631001 |
| 80 | MP0003866_abnormal_defecation | 0.84941353 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.83754360 |
| 82 | MP0009763_increased_sensitivity_to | 0.82728962 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.82593253 |
| 84 | MP0003091_abnormal_cell_migration | 0.82366365 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.81318913 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.79142038 |
| 87 | MP0008057_abnormal_DNA_replication | 0.78747596 |
| 88 | MP0003828_pulmonary_edema | 0.78689453 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.76749132 |
| 90 | MP0002102_abnormal_ear_morphology | 0.74418032 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.74178857 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.73726115 |
| 93 | MP0000249_abnormal_blood_vessel | 0.70813105 |
| 94 | MP0003690_abnormal_glial_cell | 0.70590046 |
| 95 | MP0001663_abnormal_digestive_system | 0.69078506 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.69061670 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.67178247 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.65347162 |
| 99 | MP0008004_abnormal_stomach_pH | 0.63527166 |
| 100 | MP0000371_diluted_coat_color | 0.63192295 |
| 101 | MP0005164_abnormal_response_to | 0.62919976 |
| 102 | MP0002133_abnormal_respiratory_system | 0.62576751 |
| 103 | MP0005388_respiratory_system_phenotype | 0.62576751 |
| 104 | MP0002009_preneoplasia | 0.60829689 |
| 105 | MP0003795_abnormal_bone_structure | 0.58811325 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.58703467 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.56895069 |
| 108 | MP0004381_abnormal_hair_follicle | 0.56179582 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.56111860 |
| 110 | MP0001881_abnormal_mammary_gland | 0.55295708 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.53162908 |
| 112 | MP0000920_abnormal_myelination | 0.53082524 |
| 113 | MP0001915_intracranial_hemorrhage | 0.52638750 |
| 114 | MP0005394_taste/olfaction_phenotype | 0.52296135 |
| 115 | MP0005499_abnormal_olfactory_system | 0.52296135 |
| 116 | MP0003045_fibrosis | 0.51744955 |
| 117 | MP0000627_abnormal_mammary_gland | 0.51467001 |
| 118 | MP0003186_abnormal_redox_activity | 0.49524774 |
| 119 | MP0004484_altered_response_of | 0.49097471 |
| 120 | MP0003329_amyloid_beta_deposits | 0.47723988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.48665219 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.29617809 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.76141092 |
| 4 | Optic neuritis (HP:0100653) | 5.05988040 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 5.05988040 |
| 6 | Myositis (HP:0100614) | 4.92604100 |
| 7 | Orchitis (HP:0100796) | 4.80543538 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.62221112 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.62073362 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51203377 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.36727825 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.27203616 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.24822280 |
| 14 | Stomatitis (HP:0010280) | 4.07965129 |
| 15 | Increased IgM level (HP:0003496) | 4.00307177 |
| 16 | Vasculitis (HP:0002633) | 4.00186093 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90330354 |
| 18 | Obstructive lung disease (HP:0006536) | 3.90330354 |
| 19 | Recurrent skin infections (HP:0001581) | 3.73394103 |
| 20 | Recurrent viral infections (HP:0004429) | 3.71521681 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.54528674 |
| 22 | Gingivitis (HP:0000230) | 3.47209368 |
| 23 | Chronic otitis media (HP:0000389) | 3.42730825 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.41132935 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.33132007 |
| 26 | Arterial thrombosis (HP:0004420) | 3.31661201 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.30095309 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.28726588 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.22764849 |
| 30 | Basal ganglia calcification (HP:0002135) | 3.17394680 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.13466751 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10635832 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10635832 |
| 34 | Meningitis (HP:0001287) | 3.03668369 |
| 35 | Hemoptysis (HP:0002105) | 3.02770615 |
| 36 | Periodontitis (HP:0000704) | 3.02708667 |
| 37 | Amyotrophic lateral sclerosis (HP:0007354) | 3.01158985 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.00371524 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 2.97656435 |
| 40 | Prostate neoplasm (HP:0100787) | 2.92676395 |
| 41 | Leukocytosis (HP:0001974) | 2.92598774 |
| 42 | Cellulitis (HP:0100658) | 2.88799749 |
| 43 | Pustule (HP:0200039) | 2.88034302 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.87937434 |
| 45 | T lymphocytopenia (HP:0005403) | 2.83236508 |
| 46 | Combined immunodeficiency (HP:0005387) | 2.81271648 |
| 47 | Eosinophilia (HP:0001880) | 2.71035987 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.67684332 |
| 49 | Urticaria (HP:0001025) | 2.58399850 |
| 50 | Thick nail (HP:0001805) | 2.56153197 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.55838584 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54111057 |
| 53 | Disinhibition (HP:0000734) | 2.53458454 |
| 54 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.53268312 |
| 55 | Abnormality of the prostate (HP:0008775) | 2.49392398 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49181662 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49181662 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49181662 |
| 59 | Nasal polyposis (HP:0100582) | 2.47178263 |
| 60 | Abnormality of T cells (HP:0002843) | 2.46770398 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.45120784 |
| 62 | Gingival bleeding (HP:0000225) | 2.42720322 |
| 63 | Osteomyelitis (HP:0002754) | 2.42452890 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.39471726 |
| 65 | Petechiae (HP:0000967) | 2.38308088 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.37881277 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.37511635 |
| 68 | Chest pain (HP:0100749) | 2.37084282 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36922969 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.36922969 |
| 71 | Thrombocytosis (HP:0001894) | 2.35427285 |
| 72 | Gangrene (HP:0100758) | 2.34006563 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.32240844 |
| 74 | Tetraparesis (HP:0002273) | 2.31508141 |
| 75 | Stomach cancer (HP:0012126) | 2.31395241 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.29548793 |
| 77 | Myocardial infarction (HP:0001658) | 2.28240796 |
| 78 | IgA deficiency (HP:0002720) | 2.27805059 |
| 79 | Granulocytopenia (HP:0001913) | 2.26122192 |
| 80 | Alveolar cell carcinoma (HP:0006519) | 2.24552633 |
| 81 | IgG deficiency (HP:0004315) | 2.22967435 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.22625376 |
| 83 | Abnormality of the pericardium (HP:0001697) | 2.22623286 |
| 84 | Axonal loss (HP:0003447) | 2.21674191 |
| 85 | Encephalitis (HP:0002383) | 2.21630592 |
| 86 | Anorexia (HP:0002039) | 2.20283436 |
| 87 | Papillary thyroid carcinoma (HP:0002895) | 2.17382105 |
| 88 | Increased IgE level (HP:0003212) | 2.17357666 |
| 89 | Porencephaly (HP:0002132) | 2.16973351 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 2.16901359 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.16130431 |
| 92 | Joint swelling (HP:0001386) | 2.15418274 |
| 93 | Thyroiditis (HP:0100646) | 2.14933264 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14258444 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.13648830 |
| 96 | Subacute progressive viral hepatitis (HP:0006572) | 2.13474409 |
| 97 | IgM deficiency (HP:0002850) | 2.12496959 |
| 98 | B lymphocytopenia (HP:0010976) | 2.12176580 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11197103 |
| 100 | Arthralgia (HP:0002829) | 2.09095156 |
| 101 | Viral hepatitis (HP:0006562) | 2.06024737 |
| 102 | Chronic diarrhea (HP:0002028) | 2.03787261 |
| 103 | Loss of speech (HP:0002371) | 2.03698016 |
| 104 | Keratitis (HP:0000491) | 2.03123571 |
| 105 | Polyneuropathy (HP:0001271) | 2.01944856 |
| 106 | Sepsis (HP:0100806) | 2.00575147 |
| 107 | Lymphopenia (HP:0001888) | 2.00200975 |
| 108 | Skin ulcer (HP:0200042) | 1.99941557 |
| 109 | Hematochezia (HP:0002573) | 1.99627160 |
| 110 | Premature loss of primary teeth (HP:0006323) | 1.98944779 |
| 111 | Pulmonary embolism (HP:0002204) | 1.96072520 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 1.95890191 |
| 113 | Amaurosis fugax (HP:0100576) | 1.95655394 |
| 114 | Panhypogammaglobulinemia (HP:0003139) | 1.95330950 |
| 115 | Lymphoma (HP:0002665) | 1.94422088 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89801418 |
| 117 | Cortical dysplasia (HP:0002539) | 1.88781485 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.82219925 |
| 119 | Glomerulopathy (HP:0100820) | 1.79611173 |
| 120 | Abnormality of the endocardium (HP:0004306) | 1.79453166 |
| 121 | Epistaxis (HP:0000421) | 1.77261558 |
| 122 | Recurrent sinusitis (HP:0011108) | 1.74370552 |
| 123 | Agammaglobulinemia (HP:0004432) | 1.74049123 |
| 124 | Large earlobe (HP:0009748) | 1.71095985 |
| 125 | Episodic fever (HP:0001954) | 1.67654963 |
| 126 | Peritonitis (HP:0002586) | 1.66739222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.09939208 |
| 2 | TXK | 3.81240149 |
| 3 | MAP4K1 | 3.48985119 |
| 4 | TBK1 | 3.39851432 |
| 5 | JAK3 | 3.26084359 |
| 6 | BLK | 3.02661050 |
| 7 | TYK2 | 2.99343553 |
| 8 | RIPK4 | 2.91660520 |
| 9 | IRAK4 | 2.90086804 |
| 10 | IKBKB | 2.87294682 |
| 11 | IKBKE | 2.59615667 |
| 12 | JAK1 | 2.22937365 |
| 13 | PBK | 2.14769336 |
| 14 | MAP3K13 | 2.02644313 |
| 15 | CHUK | 2.02453949 |
| 16 | KIT | 1.97506942 |
| 17 | ZAP70 | 1.90458814 |
| 18 | IRAK3 | 1.85345967 |
| 19 | PRPF4B | 1.84944174 |
| 20 | PIM2 | 1.81314939 |
| 21 | CAMKK2 | 1.77091719 |
| 22 | SYK | 1.74602910 |
| 23 | EPHB1 | 1.62037350 |
| 24 | MAP3K4 | 1.54534164 |
| 25 | TEC | 1.48588830 |
| 26 | HCK | 1.47853057 |
| 27 | FGFR3 | 1.46999310 |
| 28 | BTK | 1.44169695 |
| 29 | STK10 | 1.43312137 |
| 30 | TRIM28 | 1.41392188 |
| 31 | CSK | 1.41216276 |
| 32 | BRD4 | 1.41066727 |
| 33 | ITK | 1.37044700 |
| 34 | CSF1R | 1.36721675 |
| 35 | PIM1 | 1.36683185 |
| 36 | BMPR2 | 1.35498634 |
| 37 | KSR1 | 1.33506380 |
| 38 | LCK | 1.32843047 |
| 39 | NEK9 | 1.30912793 |
| 40 | EPHA3 | 1.29066141 |
| 41 | JAK2 | 1.18768381 |
| 42 | MST4 | 1.17298270 |
| 43 | FGFR4 | 1.15419105 |
| 44 | TAOK1 | 1.14503755 |
| 45 | LYN | 1.14424726 |
| 46 | STK4 | 1.12142203 |
| 47 | TAOK3 | 1.11001420 |
| 48 | MAP2K7 | 1.10580752 |
| 49 | TGFBR2 | 1.10022532 |
| 50 | SIK3 | 1.05401877 |
| 51 | ACVR1B | 0.97659137 |
| 52 | MARK3 | 0.94837806 |
| 53 | DYRK3 | 0.94353203 |
| 54 | KSR2 | 0.93340800 |
| 55 | CLK1 | 0.91611083 |
| 56 | RPS6KA4 | 0.89575267 |
| 57 | FES | 0.88931039 |
| 58 | EIF2AK2 | 0.85215928 |
| 59 | TRPM7 | 0.84047088 |
| 60 | PRKCQ | 0.82852381 |
| 61 | BMX | 0.81821592 |
| 62 | PIK3CG | 0.80957894 |
| 63 | RIPK1 | 0.80934306 |
| 64 | EIF2AK3 | 0.80111112 |
| 65 | FGR | 0.79577337 |
| 66 | IRAK1 | 0.77882805 |
| 67 | NME2 | 0.75611051 |
| 68 | SGK2 | 0.75595792 |
| 69 | LRRK2 | 0.67884888 |
| 70 | MAP3K6 | 0.67387821 |
| 71 | MAP2K3 | 0.64507618 |
| 72 | MAP2K4 | 0.63688824 |
| 73 | DYRK1B | 0.62592946 |
| 74 | NUAK1 | 0.60690252 |
| 75 | ABL1 | 0.59892977 |
| 76 | MAP4K2 | 0.59097232 |
| 77 | CDK19 | 0.58813310 |
| 78 | STK3 | 0.57736163 |
| 79 | PRKCD | 0.57416878 |
| 80 | MAP3K5 | 0.56343205 |
| 81 | MAPKAPK2 | 0.56309637 |
| 82 | CAMKK1 | 0.55119370 |
| 83 | YES1 | 0.54904102 |
| 84 | CDK12 | 0.54820672 |
| 85 | SIK2 | 0.54244362 |
| 86 | TAOK2 | 0.54243526 |
| 87 | PLK2 | 0.53818274 |
| 88 | SRPK1 | 0.53554038 |
| 89 | ERBB3 | 0.53080092 |
| 90 | EGFR | 0.52332610 |
| 91 | MATK | 0.52082325 |
| 92 | SGK3 | 0.51218218 |
| 93 | MAPK13 | 0.49838714 |
| 94 | WNK3 | 0.49269362 |
| 95 | NLK | 0.48344396 |
| 96 | CDK6 | 0.47854063 |
| 97 | MAP3K11 | 0.47513135 |
| 98 | GRK7 | 0.46729411 |
| 99 | GRK6 | 0.46698506 |
| 100 | TESK1 | 0.45738923 |
| 101 | ABL2 | 0.45325600 |
| 102 | SGK494 | 0.43626004 |
| 103 | SGK223 | 0.43626004 |
| 104 | MAP3K12 | 0.43421318 |
| 105 | DYRK2 | 0.42582347 |
| 106 | CAMK4 | 0.41952128 |
| 107 | MAPK7 | 0.39917554 |
| 108 | STK24 | 0.39845477 |
| 109 | CSNK1A1L | 0.39764551 |
| 110 | MOS | 0.38827938 |
| 111 | RPS6KA5 | 0.37420247 |
| 112 | MAP3K10 | 0.37297986 |
| 113 | PTK6 | 0.37066877 |
| 114 | PKN1 | 0.36124805 |
| 115 | ERN1 | 0.34938077 |
| 116 | ADRBK2 | 0.34176857 |
| 117 | BCR | 0.31436066 |
| 118 | HIPK2 | 0.29867029 |
| 119 | RPS6KA6 | 0.29588474 |
| 120 | ARAF | 0.29328834 |
| 121 | IGF1R | 0.27460852 |
| 122 | MAP3K1 | 0.25278712 |
| 123 | FYN | 0.24775724 |
| 124 | SCYL2 | 0.23743326 |
| 125 | DMPK | 0.23496042 |
| 126 | IRAK2 | 0.23479050 |
| 127 | PDGFRB | 0.22610978 |
| 128 | RPS6KA1 | 0.22378623 |
| 129 | TTN | 0.20455762 |
| 130 | INSR | 0.20399394 |
| 131 | RAF1 | 0.20380896 |
| 132 | BMPR1B | 0.19647443 |
| 133 | MAP3K8 | 0.18893663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70742241 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.59680058 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04900920 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64844632 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.58089561 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56857224 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40229913 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.36505632 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.35311981 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25993050 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20089869 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19436814 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16044216 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.05381119 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01419325 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95421608 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.94953552 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.94097491 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.92587135 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89818217 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.85203534 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82439453 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.74155682 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72730112 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66326562 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64703903 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57574595 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57556987 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55057780 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54577205 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53115858 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52761990 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52075334 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49907839 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49483910 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.46210351 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.42376406 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41469024 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39591570 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.35863778 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.26365671 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.23274067 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.21671236 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20794558 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01741599 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99917166 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97216915 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.91962229 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89276468 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87302483 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83213456 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82192156 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79290194 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77731712 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77185945 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76915470 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75867041 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.73718080 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73472163 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68666355 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.65807369 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63696244 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63486593 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61016435 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59660498 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59187085 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56153923 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55953160 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54458374 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52614336 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51140365 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48746691 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.47634405 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46950769 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45131151 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43677958 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43090344 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41179441 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39298355 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38365510 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37795793 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.37441097 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37210564 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34562136 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34467586 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34220539 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32589457 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32347161 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31673944 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31206000 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30920787 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30548462 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29515051 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28068562 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26570251 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26225407 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25492937 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24594422 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.24297314 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24073377 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23326511 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22946078 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.22370084 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21993188 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21852672 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.18258736 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18196672 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16414764 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15005600 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10303997 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.10055245 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.09841131 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09577492 |

